Company profile
Boobybiome Ltd
403 Forbidden
Boobybiome Ltd is a UK company with status active founded in 2019.
Latest accounts
Financial period: 1 Aug 2023 to 31 Jul 2024
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts filed
AccountsLast accounts made up date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Resolution
ResolutionRESOLUTIONS | Transaction WURDSkpZU0dhZGlxemtjeA | Paper/PDF filed
Published 06 Oct 2024 05:58
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Developing clinically efficacious breast milk-derived microbiome supplements for infants.
1 Jun 2024 to 31 Aug 2026
**BoobyBiome is developing a breakthrough breast milk-derived synbiotic for infants with compromised microbiomes.** The microbiome describes the microorganisms which reside on and in us. A healthy microbiome is crucial in regulating digestive, immune and metabolic functions. **Human breast milk (BM) contributes 40% of the beneficial bacteria in an infant'...
Elucidating the Mechanism of Action of Breast Milk-Derived Synbiotic Consortia in Establishing a Healthy Infant Gut
1 Apr 2024 to 30 Nov 2024
A healthy microbiome, which describes the microorganisms which reside on and in us, is crucial in regulating digestive, immune and metabolic functions. Breast milk (BM) contributes 40% of the beneficial bacteria in an infant's gut; without it, babies are vulnerable to microbiome-related diseases (necrotising enterocolitis (NEC), sepsis, diabetes, IBS, inc...
Development of a novel device to improve the breast milk microbiome
1 May 2023 to 31 Jul 2024
BoobyBiome is passionate about **empowering parents** and improving the **health of their babies** by designing products which support the infant microbiome. A healthy gut microbiome is crucial in regulating digestive, immune and metabolic functions. The breastmilk microbiome contributes **40%** of the first beneficial gut bacteria to infants. However cur...
A device for supporting the breast milk microbiome.
1 Apr 2023 to 31 Mar 2024
The **microbiome** describes the collection of microorganisms, including bacteria, which reside on and in us. A healthy microbiome is crucial in regulating digestive, immune and metabolic functions. Babies **without** access to breastmilk, which **contributes 40%** of the first beneficial bacteria in infants' guts, are **vulnerable** to microbiome-related...
The development of a live biotherapeutic product for clinical use, preventing NEC in preterm babies.
1 May 2022 to 30 Apr 2023
**BoobyBiome is developing breakthrough breast milk-derived live biotherapeutic products (LBPs) for infants with compromised microbiomes**. The microbiome describes the collection of microorganisms, including bacteria, which reside on and in us. A healthy microbiome is crucial in regulating digestive, immune and metabolic functions. Human breast milk (HBM...